07:00 , May 11, 2015 |  BC Week In Review  |  Financial News

Adaptive Biotechnologies completes venture financing

Adaptive Biotechnologies Corp. , Seattle, Wash.   Business: Bioinformatics, Diagnostic, High throughput screening   Date completed: 2015-05-06   Type: Venture financing   Raised: $195 million   Investors: Matrix Capital Management; Senator Investment Group; Tiger Management;...
08:00 , Nov 10, 2014 |  BioCentury  |  Finance

Convert resurgence

Biotechs have raised $5.6 billion through convertible debt financings so far this year, the highest amount since 2006. Two bankers attributed the resurgence to a growing mid-cap space that is taking advantage of low interest...
07:00 , Oct 6, 2014 |  BC Week In Review  |  Clinical News

BD FACSPresto Near-Patient CD4 Counter system regulatory update

Becton Dickinson's BD Biosciences division said the World Health Organization (WHO) awarded prequalification to the company's BD FACSPresto Near-Patient CD4 Counter system to measure absolute and percentage results of CD4+ T lymphocytes and hemoglobin concentration...
07:00 , Aug 4, 2014 |  BioCentury  |  Finance

Voucher leapfrog

Sanofi (Euronext:SAN; NYSE:SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) are hoping to use a newly acquired Priority Review voucher to jump ahead of Amgen Inc. (NASDAQ:AMGN) in the race to be first to market with a...
07:00 , May 5, 2014 |  BC Week In Review  |  Company News

Becton Dickinson sales and marketing update

Becton Dickinson's BD Biosciences segment launched BD FACSPresto Near Patient CD4 Counter system in countries that recognize CE Mark approval for measuring absolute and percentage results of CD4 T lymphocytes and hemoglobin concentration in blood...
07:00 , May 5, 2014 |  BioCentury  |  Finance

Pulling off the AZ gambit

Pfizer Inc. (NYSE:PFE) still has room to maneuver if it is really intent on using its bid for AstraZeneca plc (LSE:AZN; NYSE:AZN) to relocate in the more tax-friendly U.K. The trick is to provide enough...
07:00 , Apr 16, 2012 |  BC Week In Review  |  Company News

Alere, Becton Dickinson, BioGene Ltd., Inanovate UK Ltd., Mast Group Ltd., MicroLab Devices Ltd., Randox Laboratories, Sepsis Ltd., Smiths Group plc diagnostic

The U.K.'s Technology Strategy Board announced the awarding of grants totaling £8 million ($12.7 million) to 12 R&D projects on the diagnosis, detection and management of sepsis. The projects include work to develop a point-of-care...
07:00 , Apr 16, 2012 |  BC Week In Review  |  Company News

Beckton Dickinson and Co., Corning Inc. deal

Becton Dickinson will sell its BD Biosciences Discovery Labware unit to specialty glass and ceramics company Corning for about $730 million in cash. The deal excludes Becton Dickinson's Advanced Bioprocessing platform, which uses bacterial fermentation...
00:20 , Apr 11, 2012 |  BC Extra  |  Politics & Policy

U.K. awards L8 million for sepsis research

The U.K.'s Technology Strategy Board announced the awarding of grants totaling L8 million ($12.7 million) to 12 R&D projects on the diagnosis, detection and management of sepsis. The projects include work to develop a point-of-care...
07:00 , Aug 29, 2011 |  BC Week In Review  |  Company News

Merck management update

Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J.   Business: Pharmaceuticals   Hired: Richard DeLuca as EVP and president of Merck's Merck Animal Health unit, effective Sept. 15, formerly CFO of Becton Dickinson and Co....